Showing results (421-430 of 687) with videos related to
Sort By:
Pageof 69
Journal of Bone Oncology|September 27, 2017
The role of biomarkers in the management of bone-homing malignanciesStella D'Oronzo, Janet Brown, Robert ColemanJournal of Bone Oncology|November 26, 2020
Application of "omics" sciences to the prediction of bone metastases from breast cancer: State of the artMarica Gentile, Antonella Centonza, Domenica Lovero, et al.Journal of Bone Oncology|October 21, 2020
Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironmentYong Lei, Chen Junxin, Huang Yongcan, et al.Journal of Bone Oncology|June 23, 2022
Circ_0051079 silencing inhibits the malignant phenotypes of osteosarcoma cells by the TRIM66/Wnt/β-catenin pathway in a miR-625-5p-dependent mannerWeilin Wang, Jianhua Wang, Yingyi Li, et al.Journal of Bone Oncology|January 9, 2023
Diagnostic value of H3F3A mutation and clinicopathological features of giant cell tumours in non-long bonesYanli Luo, Juan Tang, Jin Huang, et al.Journal of Bone Oncology|November 24, 2022
TIAM2 promotes proliferation and invasion of osteosarcoma cells by activating the JAK2/STAT3 signaling pathwayShaohua Cheng, Xinghan Huang, Weichun GuoJournal of Bone Oncology|January 11, 2021
Effects of abiraterone acetate plus prednisone on bone turnover markers in chemotherapy-naïve mCRPC patients after ADT failure: A prospective analysis of the italian real-world study ABITUDEDaniele Santini, Saverio Cinieri, Donatello Gasparro, et al.Journal of Bone Oncology|December 23, 2022
Prevalence of low bone mineral density and risk of fractures in osteosarcoma and Ewing's sarcoma survivors: A scoping reviewKeisuke Horiuchi, Ryuji Nemoto, Tsukasa Mizuno, et al.Journal of Bone Oncology|July 8, 2022
Pexmetinib suppresses osteoclast formation and breast cancer induced osteolysis via P38/STAT3 signal pathwayZhiwei Jie, Shiyu Wang, Qingliang Ma, et al.Journal of Bone Oncology|September 30, 2020
Oestrogen and zoledronic acid driven changes to the bone and immune environments: Potential mechanisms underlying the differential anti-tumour effects of zoledronic acid in pre- and post-menopausal conditionsChristopher N George, Victor Canuas-Landero, Elizavet Theodoulou, et al.Pageof 69